“Assay”的搜索结果，显示 11-20 项，共有 5897 项

1. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... assay results. TRPC6 To Predict And Prevent Chemotherapy Related ... assays and results from a ctDNA assay by Guardant on blood. EF-41/KEYNOTE ...

3. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

4. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

5. 心血管医学- 临床试验- 妙佑医疗国际

   ... assay obtained at baseline. Genotype-Phenotype Correlation in Cardiovascular Disease. Rochester, Minn. This research study is being done to help characterize ...

6. 放射科- 临床试验- 妙佑医疗国际

   ... assay. This will be done by comparing pre-and-post MRI hs-cTnT levels in these patients. Improvements In Dynamic Contrast-Enhanced MR Angiography And ...

7. 放射科- 临床试验- 妙佑医疗国际

   ... assay. This will be done by comparing pre-and-post MRI hs-cTnT levels in these patients. Improvements In Dynamic Contrast-Enhanced MR Angiography And ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. A Pilot ...

10. 传染病- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the new QFT-Plus assay compared to the QFT-Gold assay and the tuberculin skin test results (as available) for the ...